tiprankstipranks
Trending News
More News >
Hiscox (OTC) (GB:HSX)
:HSX

Hiscox (HSX) AI Stock Analysis

Compare
28 Followers

Top Page

GB

Hiscox

(OTC:HSX)

Rating:78Outperform
Price Target:
1,512.00p
▲(14.03%Upside)
Hiscox's overall stock score is driven by strong technical indicators and positive earnings call sentiment. The company's valuation metrics suggest it may be undervalued, and recent corporate actions like share buybacks and a strategic chair appointment support a positive outlook. However, challenges in cash flow and profit margins moderate the score.

Hiscox (HSX) vs. iShares MSCI United Kingdom ETF (EWC)

Hiscox Business Overview & Revenue Model

Company DescriptionHiscox Ltd, through its subsidiaries, provides insurance and reinsurance services in the United Kingdom, Europe, the United States, and internationally. The company operates through four segments: Hiscox Retail, Hiscox London Market, Hiscox Re & ILS, and Corporate Centre. It provides commercial insurance for small-and medium-sized businesses, personal lines cover, including high-value household, fine art, luxury motor, and classic car through brokers, partners and direct-to-consumer using both traditional and digital trading models. The company also offers property insurance; marine and energy insurance; aviation insurance; casualty insurance; specialty insurance; kidnap and ransom insurance; and other specialty insurance, such as contingency, terrorism, personal accident, and product recall. In addition, it provides healthcare and casualty reinsurance services, as well as investment services. Hiscox Ltd was founded in 1901 and is based in Pembroke, Bermuda.
How the Company Makes MoneyHiscox makes money primarily through underwriting insurance policies and managing risk for clients across various sectors. The company's revenue streams include premium income from the sale of insurance policies, investment income from managing the assets generated from these premiums, and fees from advisory and risk management services. Hiscox's earnings are influenced by factors such as the volume of policies written, the claims experience, and the performance of its investment portfolio. The company also engages in strategic partnerships and collaborations to expand its market reach and enhance its product offerings.

Hiscox Earnings Call Summary

Earnings Call Date:Feb 27, 2025
(Q4-2024)
|
% Change Since: 20.83%|
Next Earnings Date:Aug 06, 2025
Earnings Call Sentiment Positive
The earnings call reflected a strong performance by Hiscox with record profits, growth across the retail segment, and significant capital returns to shareholders. Despite facing challenges from the California wildfires and increased operating expenses, the company remains confident in its growth trajectory and market positioning.
Q4-2024 Updates
Positive Updates
Record Profits and Revenue Growth
Hiscox reported record profits at $685 million for the second consecutive year, with a return on equity of 19.8%. Revenue increased by around $170 million, driven by the retail business.
Strong Performance in Retail Business
The retail business achieved a profit of approximately $300 million, with growth driven by management actions in the U.K., Europe, and the U.S. direct-to-consumer business showing double-digit growth.
Improved Combined Ratios
The group achieved an undiscounted combined ratio of 89.2% in an active loss year, demonstrating effective cycle management, with the London Market business maintaining a combined ratio in the 80% range for the fifth consecutive year.
Significant Capital Returns
Hiscox announced a 20% increase in the final dividend, a full year EPS increase of 15%, and a special return of capital of $175 million through a share buyback.
Investment Gains
The group achieved an investment return of $384 million, with the NAV per share growing by 14% year-on-year.
Positive Outlook and Growth Plans
The company plans to continue growth in retail and expects London Market to return to growth in 2025, with Re & ILS deploying incremental capital into attractive market conditions.
Negative Updates
Impact of California Wildfires
The group estimates a net loss from the California wildfires of around $170 million, impacting the Re & ILS and London Market segments.
Challenges in U.S. Broker Business
The U.S. broker business contracted by 4% in 2024, although there is an expectation of a return to growth in 2025.
Increased Operating Expenses
Operating expenses increased by 19%, reflecting brand investment and one-off costs related to the sale of DirectAsia, Thailand.
Tax Rate Increase
The group's effective tax rate is expected to increase to between 15% and 20% due to the Bermuda corporate income tax.
Casualty Market Challenges
Proactive cycle management was required in the casualty division due to less attractive market conditions, impacting growth.
Company Guidance
In the call, Hiscox provided robust guidance and detailed performance metrics for the fiscal year 2024, showcasing a strong financial position and strategic growth initiatives. The company reported a record profit of $685 million, with a significant return on equity of 19.8%. Revenue increased by $170 million, primarily driven by the retail segment, which contributed $150 million. The group achieved an undiscounted combined ratio of 89.2%, reflecting effective cycle management despite an active loss year. Hiscox announced a 20% increase in the final dividend, leading to a full-year EPS rise of 15%, and a $175 million share buyback, returning 10% of equity to shareholders. U.K. and European business segments experienced accelerated growth, with new partnerships in Spain and double-digit growth in the U.S. direct-to-consumer business. The company expanded its distribution network, adding 17 new partners in the U.S. DPD and focusing on technological advancements to enhance underwriting efficiency. Hiscox's London market business maintained a strong performance, achieving an undiscounted combined ratio in the 80% range for the fifth consecutive year, while the Re & ILS segment saw net premiums increase by 11%, with a combined ratio of 69%. The company generated a record fee income of $128 million and completed a favorable January renewal season. Looking ahead to 2025, Hiscox expects retail growth to exceed 6%, with continued favorable conditions in the London market property segment and incremental capital deployment in Re & ILS.

Hiscox Financial Statement Overview

Summary
Hiscox's financial performance shows stable revenue growth and improved operational efficiency. However, there are challenges in profit margins and cash flow generation. The balance sheet reflects solid equity growth and better leverage management, though profitability on equity has declined.
Income Statement
75
Positive
Hiscox's income statement reveals a moderate revenue growth rate with a 2.66% increase from 2023 to 2024. The gross profit margin holds steady at 100% due to the nature of the insurance industry. However, the net profit margin slightly declined to 17.06% from 19.89% the previous year. The EBIT margin is not applicable for 2024, indicating potential volatility in operating income. The EBITDA margin improved, reflecting better operational efficiency.
Balance Sheet
70
Positive
The balance sheet shows strong equity growth, with the equity ratio improving to 32.81% in 2024 from 29.79% in 2023, indicating enhanced financial stability. The debt-to-equity ratio decreased, reflecting improved leverage management, though still slightly high at 0.20. ROE decreased to 17.01% from 21.61%, pointing to reduced profitability on equity.
Cash Flow
60
Neutral
Cash flow analysis shows a significant decrease in free cash flow from 188.4M in 2023 to 75.3M in 2024, indicating cash generation challenges. The operating cash flow to net income ratio dropped to 0.18 from 0.33, suggesting potential cash flow issues relative to net income, while free cash flow to net income ratio also declined, raising concerns about cash efficiency.
Breakdown
TTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
3.78B3.68B3.58B3.05B3.29B3.25B
Gross Profit
3.78B3.68B3.58B3.05B3.29B3.25B
EBIT
1.40B0.003.61B92.80M189.90M-256.50M
EBITDA
125.50M799.20M730.00M152.80M248.20M-199.70M
Net Income Common Stockholders
720.80M627.20M712.00M41.70M189.50M-293.70M
Balance SheetCash, Cash Equivalents and Short-Term Investments
549.06M1.23B1.47B1.40B1.35B1.64B
Total Assets
6.16B11.24B11.06B13.72B13.85B13.86B
Total Debt
30.94M743.00M754.20M635.90M746.50M946.10M
Net Debt
-494.28M-484.00M-682.80M-715.00M-554.20M-631.10M
Total Liabilities
4.21B7.55B7.76B11.31B11.31B11.50B
Stockholders Equity
1.95B3.69B3.30B2.42B2.54B2.35B
Cash FlowFree Cash Flow
364.10M75.30M188.40M290.60M-42.30M-188.60M
Operating Cash Flow
367.00M114.40M232.10M373.40M16.60M-117.10M
Investing Cash Flow
-29.70M-38.50M-34.20M-81.90M-36.60M-52.70M
Financing Cash Flow
-255.10M-282.60M-128.90M-190.90M-246.20M592.80M

Hiscox Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1326.00
Price Trends
50DMA
1164.77
Positive
100DMA
1122.46
Positive
200DMA
1107.80
Positive
Market Momentum
MACD
43.11
Negative
RSI
79.16
Negative
STOCH
93.38
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:HSX, the sentiment is Positive. The current price of 1326 is above the 20-day moving average (MA) of 1222.95, above the 50-day MA of 1164.77, and above the 200-day MA of 1107.80, indicating a bullish trend. The MACD of 43.11 indicates Negative momentum. The RSI at 79.16 is Negative, neither overbought nor oversold. The STOCH value of 93.38 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:HSX.

Hiscox Peers Comparison

Overall Rating
UnderperformOutperform
Sector (64)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
GBBEZ
79
Outperform
£5.91B7.0226.32%2.60%7.79%9.99%
GBADM
79
Outperform
£10.18B15.5056.17%5.78%34.86%95.18%
GBHSX
78
Outperform
£4.41B9.2517.96%2.37%3.60%-13.17%
GBLRE
78
Outperform
£1.43B5.6121.23%2.87%14.46%-2.98%
65
Neutral
£329.50M9.1914.37%10.11%32.88%99.17%
64
Neutral
$12.77B9.777.59%16985.66%12.31%-7.69%
GBDLG
63
Neutral
£3.88B26.935.97%2.34%26.11%-29.43%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:HSX
Hiscox
1,326.00
228.26
20.79%
GB:BEZ
Beazley
962.50
304.35
46.24%
GB:ADM
Admiral
3,356.00
857.40
34.32%
GB:DLG
Direct Line Insurance
302.40
101.32
50.39%
GB:LRE
Lancashire Holdings
591.00
72.21
13.92%
GB:SBRE
Sabre Insurance Group plc
133.00
-15.29
-10.31%

Hiscox Corporate Events

Delistings and Listing ChangesDividends
Hiscox Ltd Seeks Listing for New Ordinary Shares
Positive
Jun 6, 2025

Hiscox Ltd has announced its application to have 146,706 Ordinary Shares admitted to the Official List of the Financial Conduct Authority and the London Stock Exchange. These shares are part of the company’s Scrip Dividend Alternative related to the final dividend and are expected to be listed on June 9, 2025. This move is likely to enhance the company’s financial flexibility and provide shareholders with additional options for dividend reinvestment, potentially strengthening Hiscox’s market position.

The most recent analyst rating on (GB:HSX) stock is a Hold with a £14.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.

Other
Hiscox Announces Change in Major Shareholder Voting Rights
Neutral
Jun 5, 2025

Hiscox Ltd has announced a change in the voting rights held by Boston Partners, formerly known as Robeco Investment Management, Inc., which is based in New York, USA. As of June 2, 2025, Boston Partners’ voting rights in Hiscox have decreased from 5.298% to 4.93%, marking a disposal of voting rights. This change may impact Hiscox’s shareholder dynamics and influence within the company, although the broader implications for stakeholders are not detailed in the release.

The most recent analyst rating on (GB:HSX) stock is a Buy with a £1500.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.

Stock BuybackBusiness Operations and Strategy
Hiscox Ltd Executes Share Buyback Program
Positive
Jun 5, 2025

Hiscox Ltd has executed a share buyback program, purchasing 40,000 ordinary shares at a volume-weighted average price of 1,302.50 GBp per share. This move is part of a previously announced buyback initiative, reflecting the company’s strategy to manage its capital structure and potentially enhance shareholder value.

The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.

Private Placements and FinancingBusiness Operations and Strategy
Hiscox Ltd Announces $500 Million Tender Offer for Subordinated Notes
Neutral
Jun 4, 2025

Hiscox Ltd has announced the U.S. dollar Maximum Acceptance Amount for its tender offer concerning its Fixed to Floating Rate Callable Subordinated Notes due 2045. The company has set the Maximum Acceptance Amount at $500 million, which will be converted into sterling based on the prevailing exchange rate at the expiration deadline. This move is part of Hiscox’s strategic financial management, potentially impacting its financial structure and market positioning.

The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.

Stock Buyback
Hiscox Executes Share Buyback Program
Positive
Jun 4, 2025

Hiscox Ltd has executed a share buyback program, purchasing 40,000 ordinary shares at an average price of 1,283.18 GBp per share. This move is part of a previously announced buyback initiative, and the purchased shares will be cancelled, potentially enhancing shareholder value and reflecting confidence in the company’s financial health.

The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.

Stock Buyback
Hiscox Executes Share Buyback to Enhance Shareholder Value
Positive
Jun 3, 2025

Hiscox Ltd has executed a share buyback program, purchasing 45,000 of its own ordinary shares at prices ranging from 1,268.00 GBp to 1,284.00 GBp, with a volume-weighted average price of 1,275.11 GBp. This move is part of a previously announced buyback programme aimed at enhancing shareholder value by reducing the number of outstanding shares, which can positively impact earnings per share and market perception.

The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.

Regulatory Filings and Compliance
Hiscox Ltd Announces Total Voting Rights Update
Neutral
Jun 2, 2025

Hiscox Ltd has announced its total voting rights as of May 30, 2025, with an issued ordinary share capital of 344,616,100 shares, of which 7,523,190 are held in Treasury and do not carry voting rights. This results in a total of 337,092,910 voting rights, which shareholders can use to calculate their interests in accordance with the Disclosure and Transparency Rules.

The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.

Private Placements and FinancingBusiness Operations and Strategy
Hiscox Announces Tender Offer for Subordinated Notes
Neutral
Jun 2, 2025

Hiscox Ltd has announced a tender offer for its £275,000,000 Fixed to Floating Rate Callable Subordinated Notes due 2045, inviting holders to tender their notes for purchase. This move is part of Hiscox’s strategy to refinance existing debt and manage its debt maturity profile proactively. The offer includes the issuance of new U.S. dollar-denominated fixed to floating rate callable subordinated notes, contingent upon market conditions. This financial maneuver is expected to impact Hiscox’s operations by optimizing its debt structure, potentially affecting stakeholders who hold or intend to purchase these financial instruments.

The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.

Stock BuybackBusiness Operations and Strategy
Hiscox Executes Share Buyback to Enhance Shareholder Value
Positive
Jun 2, 2025

Hiscox Ltd has executed a share buyback transaction as part of its previously announced Buyback Programme, purchasing 25,000 Ordinary Shares at a volume weighted average price of 1,274.40 GBp. This move is part of the company’s strategy to manage its capital structure and enhance shareholder value by reducing the number of shares in circulation.

The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.

Stock BuybackBusiness Operations and Strategy
Hiscox Ltd Executes Share Buyback Program
Positive
Jun 2, 2025

Hiscox Ltd has executed a share buyback program, purchasing 25,000 of its own ordinary shares through Peel Hunt LLP. The shares were bought at prices ranging from 1,272.00 GBp to 1,281.00 GBp and will be cancelled, reflecting the company’s strategic move to manage its capital structure and potentially enhance shareholder value.

The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.

Stock BuybackBusiness Operations and Strategy
Hiscox Executes Share Buyback to Enhance Shareholder Value
Positive
May 30, 2025

Hiscox Ltd has executed a share buyback, purchasing 25,000 of its own ordinary shares as part of its previously announced Buyback Programme. The shares were bought at prices ranging from 1,251.00 GBp to 1,262.00 GBp and will be cancelled, reflecting the company’s strategy to manage its capital structure and enhance shareholder value.

The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.

Stock Buyback
Hiscox Executes Share Buyback Program
Neutral
May 29, 2025

Hiscox Ltd has executed a share buyback program, purchasing 40,000 of its own ordinary shares at a volume-weighted average price of 1,260.46 GBp per share. This move is part of a previously announced buyback strategy and the purchased shares will be cancelled, potentially impacting the company’s share value and capital structure.

The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.

Executive/Board ChangesBusiness Operations and Strategy
Hiscox Appoints Peter Clarke as New Chair to Drive Expansion
Positive
May 29, 2025

Hiscox Ltd has announced the appointment of Peter Clarke as Chair designate, effective from July 1, 2025, pending regulatory approval. Clarke brings extensive experience from his roles in financial services and insurance, which is expected to support Hiscox’s ambitious expansion plans and strengthen its position in the insurance market. Hiscox’s CEO, Aki Hussain, expressed confidence in Clarke’s ability to contribute to the company’s growth, while also acknowledging the contributions of outgoing Interim Chair Colin Keogh.

The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.

Dividends
Hiscox Announces Correction to Dividend Payment Date
Neutral
May 28, 2025

Hiscox Ltd announced a correction to the payment date for its final dividend, now set for 9 June 2025, while maintaining all other details unchanged. The company is offering a scrip dividend alternative, with the Scrip Reference Share Price calculated at 1,237p based on recent market data, impacting shareholders who opted for this alternative.

The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.

DividendsBusiness Operations and Strategy
Hiscox Announces Scrip Dividend Reference Price
Neutral
May 28, 2025

Hiscox Ltd has announced the Scrip Reference Share Price for its scrip dividend alternative, set at 1,237p. This price is determined based on the average closing market quotations from the London Stock Exchange over a specified period. The scrip dividend alternative allows shareholders to receive dividends in the form of additional shares rather than cash, with the Pound Sterling equivalent of the dividend being 22.23p per share. This move could impact shareholder value and influence the company’s financial strategy by offering flexibility in dividend payments.

The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.

Stock BuybackBusiness Operations and Strategy
Hiscox Executes Share Buyback, Cancels 29,000 Shares
Neutral
May 28, 2025

Hiscox Ltd has announced the purchase of 29,000 of its own ordinary shares as part of its share buyback programme, which was initially announced in February 2025. The shares were bought at a volume-weighted average price of 1,257.17 GBp and will be cancelled, reflecting the company’s strategy to manage its capital structure and return value to shareholders.

The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.

Stock BuybackBusiness Operations and Strategy
Hiscox Executes Share Buyback to Enhance Shareholder Value
Positive
May 27, 2025

Hiscox Ltd has announced the purchase and cancellation of 40,000 of its own ordinary shares as part of its share buyback program, executed through Peel Hunt LLP. This move is part of a strategic effort to manage the company’s capital structure and potentially enhance shareholder value, reflecting confidence in its financial position and future prospects.

The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.

Stock BuybackBusiness Operations and Strategy
Hiscox Ltd Executes Share Buyback as Part of Capital Strategy
Positive
May 23, 2025

Hiscox Ltd has executed a share buyback transaction as part of its ongoing Buyback Programme, purchasing 36,382 ordinary shares at an average price of 1,192.39 GBp per share. This move is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value by reducing the number of shares outstanding.

The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.

DividendsBusiness Operations and Strategy
Hiscox Unveils Strategic Growth Plans and Enhanced Shareholder Returns
Positive
May 22, 2025

Hiscox Ltd hosted a Capital Markets Day, highlighting its strategy to deliver sustainable returns through its diversified business model and technical capabilities. The company outlined plans for its Retail business to capture opportunities in a $317 billion market, aiming for double-digit premium growth by 2028. Hiscox also announced initiatives to enhance growth and efficiency, targeting a $200 million annualized P&L benefit by 2028, and introduced new capital efficiency measures to maximize shareholder returns. The company is setting new guidance for enhanced shareholder returns, including a mid-teens operating return on tangible equity and a 20% increase in the final dividend per share for 2025.

The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.

Stock BuybackBusiness Operations and Strategy
Hiscox Advances Share Buyback Program with New Share Purchase
Positive
May 22, 2025

Hiscox Ltd has announced the purchase of 55,000 of its own ordinary shares as part of its share buyback program. The shares were bought at prices ranging from 1,193.00 GBp to 1,203.00 GBp, with a volume-weighted average price of 1,198.02 GBp. This move is part of Hiscox’s strategy to enhance shareholder value by reducing the number of outstanding shares, which may positively impact the company’s earnings per share and market perception.

The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.

Stock BuybackBusiness Operations and Strategy
Hiscox Executes Share Buyback Program
Positive
May 21, 2025

Hiscox Ltd has executed a share buyback program, purchasing 45,000 of its own ordinary shares at a volume-weighted average price of 1,196.24 GBp per share. The shares were bought through Peel Hunt LLP and will be canceled, reflecting the company’s strategic decision to manage its capital structure and potentially enhance shareholder value.

The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.

Stock BuybackBusiness Operations and Strategy
Hiscox Ltd Advances Share Buyback Program with Recent Purchase
Positive
May 20, 2025

Hiscox Ltd has announced the purchase of 40,000 of its own ordinary shares as part of its ongoing share buyback program. The shares were acquired at prices ranging from 1,174.00 GBp to 1,192.00 GBp, with a volume-weighted average price of 1,182.82 GBp. This move is part of the company’s strategy to manage its capital structure and return value to shareholders, potentially impacting its stock market performance and investor relations.

The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.

Executive/Board ChangesShareholder MeetingsDividends
Hiscox Ltd Successfully Passes All AGM Resolutions
Positive
May 16, 2025

Hiscox Ltd announced that all resolutions proposed at its Annual General Meeting on May 15, 2025, were approved by the required majority. This includes key resolutions such as the approval of the final dividend for 2024, the 2025 Scrip Dividend Scheme, and the reappointment of several directors and auditors. The successful passing of these resolutions reflects strong shareholder support and positions the company for continued stability and growth in its operations.

The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.

Executive/Board Changes
Hiscox Appoints Jane Guyett as Senior Independent Director
Neutral
May 16, 2025

Hiscox Ltd has appointed Jane Guyett as the new Senior Independent Director, effective immediately. Jane, who joined the Board in September 2024, will replace Lynn Pike following her departure after completing a nine-year term. This leadership change is part of Hiscox’s ongoing efforts to maintain strong governance and strategic direction.

The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.

Stock BuybackBusiness Operations and Strategy
Hiscox Ltd Executes Share Buyback to Enhance Shareholder Value
Positive
May 15, 2025

Hiscox Ltd has announced the purchase of 15,000 of its own ordinary shares as part of its ongoing share buyback programme. The shares were acquired at a volume-weighted average price of 1,154.31 GBp and will subsequently be cancelled. This move is part of Hiscox’s strategy to manage its capital structure and return value to shareholders, potentially impacting the company’s stock value and market perception.

The most recent analyst rating on (GB:HSX) stock is a Hold with a £12.40 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.

Stock BuybackBusiness Operations and Strategy
Hiscox Executes Share Buyback of 40,000 Shares
Positive
May 14, 2025

Hiscox Ltd has announced the purchase of 40,000 of its own ordinary shares as part of a share buyback program initiated earlier in the year. The shares were bought at varying prices, with a volume-weighted average price of 1,145.27 GBp. This move is part of Hiscox’s strategy to manage its capital structure and return value to shareholders, potentially impacting its market positioning by reducing the number of shares outstanding.

The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.

Business Operations and StrategyFinancial Disclosures
Hiscox Announces Updated Estimates for Syndicates 33 and 6104
Neutral
May 13, 2025

Hiscox Ltd has announced the current estimates for its Syndicate 33 and Syndicate 6104 for the 2023 and 2024 accounts. The estimates show slight adjustments in expected returns as a percentage of capacity, with Syndicate 33’s 2023 estimates ranging from 11.3% to 21.3% and Syndicate 6104’s 2023 estimates from 29.7% to 39.7%. These updates reflect Hiscox’s ongoing strategy to manage its diverse insurance portfolio and maintain profitable growth, impacting stakeholders by potentially altering expected returns.

The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.

Stock Buyback
Hiscox Ltd Executes Share Buyback to Enhance Shareholder Value
Positive
May 13, 2025

Hiscox Ltd has announced the purchase of 40,000 of its own ordinary shares as part of its ongoing share buyback programme. The transaction, executed through Peel Hunt LLP, involved shares purchased at prices ranging from 1,147.00 GBp to 1,159.00 GBp, with a volume-weighted average price of 1,151.49 GBp. The acquired shares will be cancelled, which is expected to enhance shareholder value by reducing the number of shares outstanding, potentially increasing earnings per share and reflecting confidence in the company’s financial health.

The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.30 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.

Business Operations and Strategy
Capital Group Adjusts Stake in Hiscox Ltd
Neutral
May 12, 2025

The Capital Group Companies, Inc., based in Los Angeles, has adjusted its voting rights in Hiscox Ltd, reducing its stake from 5.0658% to 4.959098%. This change in holdings reflects a minor adjustment in the investment strategy of Capital Group, which manages assets for various investment entities and clients. The adjustment in voting rights may have implications for Hiscox’s shareholder dynamics and influence within the company.

The most recent analyst rating on (GB:HSX) stock is a Hold with a £13.3000 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.

Stock Buyback
Hiscox Ltd Continues Share Buyback Program with Recent Purchase
Positive
May 12, 2025

Hiscox Ltd announced the purchase of 40,000 of its own ordinary shares as part of its ongoing share buyback program. The shares were bought at prices ranging from 1,137.00 to 1,149.00 pence and will be cancelled, potentially enhancing shareholder value by reducing the number of shares in circulation.

Stock BuybackBusiness Operations and Strategy
Hiscox Ltd Advances Share Buyback Programme with Recent Share Repurchase
Positive
May 9, 2025

Hiscox Ltd has announced the repurchase of 40,000 of its own ordinary shares as part of its ongoing share buyback programme, initially announced in February 2025. The shares were purchased at a volume-weighted average price of 1,155.39 pence per share and will be cancelled, reflecting the company’s strategy to enhance shareholder value and optimize its capital structure.

Stock BuybackBusiness Operations and Strategy
Hiscox Ltd Executes Share Buyback, Acquiring 40,000 Shares
Positive
May 8, 2025

Hiscox Ltd has announced the purchase of 40,000 of its own ordinary shares as part of its ongoing share buyback program. The shares were bought at prices ranging from 1,138.00 GBp to 1,150.00 GBp, with a volume-weighted average price of 1,142.88 GBp. This move is part of Hiscox’s strategy to enhance shareholder value and optimize its capital structure, potentially impacting its stock market performance and investor confidence.

Stock BuybackBusiness Operations and Strategy
Hiscox Ltd Executes Share Buyback Program
Positive
May 8, 2025

Hiscox Ltd has announced the purchase of 40,000 of its own ordinary shares as part of its ongoing share buyback program. The shares were acquired at prices ranging from 1,138.00 GBp to 1,150.00 GBp, with a volume-weighted average price of 1,142.88 GBp. This move is part of Hiscox’s strategy to manage its capital efficiently and may impact shareholder value positively by reducing the number of shares in circulation.

Stock BuybackBusiness Operations and Strategy
Hiscox Executes Share Buyback Program
Neutral
May 7, 2025

Hiscox Ltd has executed a share buyback program, purchasing 44,143 ordinary shares at prices ranging from 1,136.00 GBp to 1,153.00 GBp, with a volume-weighted average price of 1,147.41 GBp. The repurchased shares will be canceled, which is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value.

Stock Buyback
Hiscox Announces Share Buyback of 70,000 Shares
Positive
May 6, 2025

Hiscox Ltd has announced the purchase of 70,000 of its own ordinary shares as part of its share buyback program. The shares were acquired at a volume-weighted average price of 1,117.44 GBp and will be cancelled, which may impact the company’s share capital structure and potentially enhance shareholder value.

Stock BuybackBusiness Operations and Strategy
Hiscox Executes Share Buyback Program
Positive
May 2, 2025

Hiscox Ltd has executed a share buyback program, purchasing 100,000 of its own ordinary shares at prices ranging from 1,085.00 GBp to 1,109.00 GBp, with an average price of 1,099.64 GBp per share. This move is part of a previously announced buyback initiative and reflects the company’s strategy to manage its capital structure effectively, potentially signaling confidence in its financial health and future prospects.

Regulatory Filings and Compliance
Hiscox Ltd Announces Total Voting Rights Update
Neutral
May 1, 2025

Hiscox Ltd has announced its total voting rights as of April 30, 2025, with an issued ordinary share capital of 345,677,555 shares, out of which 7,523,190 are held in Treasury and do not carry voting rights. This results in a total of 338,154,365 voting rights for shareholders, which is crucial for determining their notification requirements under the Disclosure and Transparency Rules.

Business Operations and StrategyFinancial Disclosures
Hiscox Ltd Reports Growth in Q1 2025 with Strong Retail and London Market Performance
Positive
May 1, 2025

Hiscox Ltd reported a 2.4% increase in group insurance contract written premiums for the first quarter of 2025, driven by growth in its Retail and London Market segments. The company is experiencing strong momentum in Europe and the US, with new commercial deals and partnerships contributing to its growth. Despite some rate reductions in certain areas, Hiscox maintains a disciplined approach to underwriting, and its investment result for the period was $114.1 million. The company’s strategic initiatives and market positioning are expected to continue supporting its growth trajectory.

Stock BuybackBusiness Operations and Strategy
Hiscox Ltd Executes Share Buyback Program
Positive
May 1, 2025

Hiscox Ltd has executed a share buyback program, purchasing 100,000 of its own ordinary shares at a volume-weighted average price of 1,098.07 GBp per share. This move is part of their strategic financial management to optimize capital structure and potentially enhance shareholder value by reducing the number of shares outstanding.

Stock BuybackBusiness Operations and Strategy
Hiscox Ltd Announces Share Buyback Completion
Positive
May 1, 2025

Hiscox Ltd has executed a share buyback program, purchasing 100,000 ordinary shares at an average price of 1,098.07 GBp per share. This move is part of a strategic initiative to manage the company’s capital structure and could potentially enhance shareholder value by reducing the number of shares outstanding.

Stock BuybackBusiness Operations and Strategy
Hiscox Executes Share Buyback of 90,000 Shares
Positive
Apr 30, 2025

Hiscox Ltd announced the purchase of 90,000 of its own ordinary shares as part of its share buyback program. The shares were bought at a volume-weighted average price of 1,070.12 GBp and will be canceled, reflecting the company’s strategy to manage its capital structure and potentially enhance shareholder value.

Stock Buyback
Hiscox Executes Share Buyback to Optimize Capital Structure
Positive
Apr 29, 2025

Hiscox Ltd has executed a share buyback transaction, purchasing 80,000 of its ordinary shares at prices ranging from 1,099.00 GBp to 1,111.00 GBp, with a volume-weighted average price of 1,102.68 GBp. This move is part of its previously announced share buyback programme and is likely aimed at optimizing the company’s capital structure, potentially enhancing shareholder value by reducing the number of shares outstanding.

Stock BuybackBusiness Operations and Strategy
Hiscox Advances Share Buyback Programme with Recent Share Purchase
Positive
Apr 25, 2025

Hiscox Ltd announced the purchase of 25,000 ordinary shares as part of its ongoing share buyback programme. The shares were acquired at a volume-weighted average price of 1,147.51 GBp and will be cancelled, reflecting the company’s strategy to enhance shareholder value and optimize its capital structure.

Stock BuybackBusiness Operations and Strategy
Hiscox Ltd Executes Share Buyback to Enhance Shareholder Value
Positive
Apr 24, 2025

Hiscox Ltd has executed a share buyback program, purchasing 40,000 ordinary shares at an average price of 1,179.56 GBp per share. This move is part of a broader strategy to enhance shareholder value by reducing the number of shares in circulation, potentially increasing earnings per share and signaling confidence in the company’s financial health.

Stock Buyback
Hiscox Executes Share Buyback Program
Positive
Apr 23, 2025

Hiscox Ltd has executed a share buyback program, purchasing 27,795 of its own ordinary shares through Peel Hunt LLP. The shares, bought at prices ranging from 1,163.00 GBp to 1,175.00 GBp, will be cancelled, potentially impacting the company’s share value and market perception positively by reducing the number of shares outstanding.

Stock BuybackBusiness Operations and Strategy
Hiscox Executes Share Buyback Program
Positive
Apr 23, 2025

Hiscox Ltd has executed a share buyback program, purchasing 27,795 of its own ordinary shares at prices ranging from 1,163.00 GBp to 1,175.00 GBp, with a volume-weighted average price of 1,169.67 GBp. This move is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value by reducing the number of shares outstanding.

Business Operations and StrategyRegulatory Filings and Compliance
Hiscox Ltd Announces Changes in Major Shareholder Holdings
Neutral
Apr 22, 2025

Hiscox Ltd has announced a change in its major holdings, with T. Rowe Price Associates, Inc. reducing its voting rights in the company from 5.093256% to 4.998080%. This adjustment in holdings could impact Hiscox’s shareholder dynamics and influence its strategic decisions, reflecting a shift in investment strategy by a significant stakeholder.

Stock BuybackBusiness Operations and Strategy
Hiscox Ltd Executes Share Buyback Program
Positive
Apr 17, 2025

Hiscox Ltd has executed a share buyback program, purchasing 45,000 of its own ordinary shares at a consistent price of 1,157 GBp per share. This move, conducted through Peel Hunt LLP, is part of a previously announced buyback initiative and reflects the company’s strategy to manage its capital structure effectively. The purchased shares will be cancelled, which may impact the company’s share value and benefit shareholders by potentially increasing earnings per share.

Business Operations and StrategyRegulatory Filings and Compliance
Hiscox Voting Rights Update: FMR LLC Increases Stake
Neutral
Apr 16, 2025

Hiscox Ltd has reported a change in its voting rights, with FMR LLC, a Boston-based entity, increasing its stake to 5.0027% from a previous 4.84%. This acquisition of voting rights signifies a strategic move by FMR LLC, potentially impacting Hiscox’s shareholder dynamics and influencing future company decisions.

Stock BuybackBusiness Operations and Strategy
Hiscox Executes Strategic Share Buyback
Positive
Apr 16, 2025

Hiscox Ltd has executed a share buyback program, purchasing 45,000 of its own ordinary shares at a volume-weighted average price of 1,160.82 GBp per share. This move is part of a strategic initiative to optimize the company’s capital structure and potentially enhance shareholder value by reducing the number of shares in circulation.

Stock BuybackBusiness Operations and Strategy
Hiscox Executes Share Buyback to Optimize Capital Structure
Positive
Apr 15, 2025

Hiscox Ltd has announced the purchase of 45,000 of its own ordinary shares as part of its share buyback programme. The shares were bought at a volume-weighted average price of 1,133.11 GBp and will be cancelled, reflecting the company’s strategic move to manage its capital structure and potentially enhance shareholder value.

Stock Buyback
Hiscox Executes Share Buyback, Cancelling 49,545 Shares
Positive
Apr 14, 2025

Hiscox Ltd has executed a share buyback transaction as part of its ongoing Buyback Programme, purchasing 49,545 Ordinary Shares through Peel Hunt LLP. The shares, bought at an average price of 1,110.19 GBp, will be cancelled, which may impact the company’s share capital structure and potentially enhance shareholder value.

Stock BuybackBusiness Operations and Strategy
Hiscox Ltd Executes Share Buyback of 100,000 Shares
Positive
Apr 11, 2025

Hiscox Ltd has announced the repurchase of 100,000 of its own ordinary shares as part of its ongoing share buyback program. The shares were purchased at prices ranging from 1,120.58 GBp to 1,150.00 GBp and will be cancelled, reflecting the company’s strategy to enhance shareholder value and optimize its capital structure.

Executive/Board ChangesBusiness Operations and Strategy
Hiscox Ltd Grants Deferred Bonus Awards to Executive Directors
Positive
Apr 11, 2025

Hiscox Ltd has announced the granting of deferred bonus awards to its Executive Directors under the company’s Deferred Bonus Plan. These awards, based on 40% of the 2023 bonus, will vest in March 2027, aligning executive incentives with long-term company performance. This move is part of Hiscox’s strategy to retain top management and align their interests with shareholders, potentially impacting the company’s operational stability and market positioning.

Executive/Board ChangesBusiness Operations and Strategy
Hiscox Ltd Grants Deferred Bonus Awards to Executive Directors
Positive
Apr 11, 2025

Hiscox Ltd has announced the granting of awards to its Executive Directors under the company’s Deferred Bonus Plan. These awards, which are to be delivered in the form of ordinary shares, are equivalent to 40% of the bonus awarded to each director for 2024 and will vest on March 25, 2028, contingent on continued service. This move aligns with the company’s strategic compensation practices aimed at retaining top management talent, potentially impacting its operational stability and market positioning.

Stock BuybackBusiness Operations and Strategy
Hiscox Ltd Executes Share Buyback to Enhance Shareholder Value
Positive
Apr 10, 2025

Hiscox Ltd has announced the purchase of 120,000 of its own ordinary shares as part of its share buyback program, with prices ranging from 1,070.00 GBp to 1,111.00 GBp. This move is part of the company’s strategy to enhance shareholder value and optimize its capital structure, potentially impacting its market positioning and signaling confidence in its financial health.

Executive/Board Changes
Hiscox Grants Performance-Based Share Options to Executive Directors
Neutral
Apr 10, 2025

Hiscox Ltd has announced the granting of nil-cost options to its executive directors under the company’s Performance Share Plan. These awards, which are contingent upon meeting specific performance conditions over a three-year period, aim to incentivize growth in Net Asset Value and Total Shareholder Return. The awards, granted in Bermuda, will vest in April 2028, reflecting Hiscox’s commitment to aligning executive compensation with long-term company performance and shareholder interests.

Stock BuybackBusiness Operations and Strategy
Hiscox Ltd Executes Share Buyback to Enhance Shareholder Value
Positive
Apr 9, 2025

Hiscox Ltd has announced the repurchase of 120,000 of its own ordinary shares as part of its ongoing share buyback program. The shares were purchased at prices ranging from 1,052.00 GBp to 1,107.00 GBp, with a volume-weighted average price of 1,076.23 GBp. This move is part of Hiscox’s strategy to enhance shareholder value and optimize its capital structure, potentially impacting its market positioning and investor confidence.

Stock Buyback
Hiscox Executes Share Buyback to Enhance Shareholder Value
Positive
Apr 8, 2025

Hiscox Ltd has announced the purchase of 120,000 of its own ordinary shares as part of its ongoing share buyback program. The shares were bought at prices ranging from 1,044.00 GBp to 1,098.00 GBp and will be cancelled, which is expected to enhance shareholder value and optimize the company’s capital structure.

Stock BuybackBusiness Operations and Strategy
Hiscox Announces Share Buyback of 50,000 Shares
Positive
Apr 7, 2025

Hiscox Ltd has announced a transaction involving the repurchase of 50,000 of its own ordinary shares as part of its share buyback program. The shares were purchased through Peel Hunt LLP, with prices ranging from 1,103.00 GBp to 1,163.00 GBp, and will be subsequently cancelled. This move is part of Hiscox’s strategy to manage its capital structure and potentially enhance shareholder value.

Stock BuybackBusiness Operations and Strategy
Hiscox Ltd Executes Share Buyback of 40,000 Shares
Positive
Apr 4, 2025

Hiscox Ltd has announced the purchase of 40,000 of its own ordinary shares as part of its share buyback programme, with prices ranging from 1,186.00 GBp to 1,199.00 GBp. This move is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value by reducing the number of shares in circulation.

Executive/Board Changes
Hiscox Ltd Completes CFO’s Performance Share Plan Award Vesting
Neutral
Apr 3, 2025

Hiscox Ltd announced the vesting of the final tranche of a buy-out award for Paul Cooper, the Chief Financial Officer, under the company’s Performance Share Plan. This award, comprising 11,037 ordinary shares, vested on April 1, 2025, with an additional 734 shares granted as dividend equivalents. This transaction is part of the company’s ongoing efforts to align executive compensation with performance, potentially impacting the company’s financial management and stakeholder interests.

Stock BuybackBusiness Operations and Strategy
Hiscox Executes Share Buyback Program
Positive
Apr 3, 2025

Hiscox Ltd has executed a share buyback program, purchasing 40,000 of its own ordinary shares through Peel Hunt LLP. The shares were bought at prices ranging from 1,187.00 GBp to 1,210.00 GBp, with a volume-weighted average price of 1,197.23 GBp. This move is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value by reducing the number of shares outstanding.

Stock BuybackBusiness Operations and Strategy
Hiscox Executes Share Buyback of 50,000 Shares
Positive
Apr 2, 2025

Hiscox Ltd has announced the purchase of 50,000 of its own ordinary shares as part of a share buyback programme initiated earlier this year. The shares were acquired at a volume-weighted average price of 1,190.53 GBp and will be cancelled, reflecting the company’s strategy to enhance shareholder value and optimize its capital structure.

Regulatory Filings and Compliance
Hiscox Ltd Updates Total Voting Rights for Shareholders
Neutral
Apr 1, 2025

Hiscox Ltd has announced an update on its total voting rights as of March 31, 2025. The company reported that its issued ordinary share capital consists of 346,814,882 Ordinary Shares, with 7,523,190 of these shares held in Treasury, which do not carry voting rights. Consequently, the total number of voting rights available to shareholders is 339,291,692. This information is crucial for shareholders to determine their notification requirements under the Disclosure and Transparency Rules.

Stock BuybackBusiness Operations and Strategy
Hiscox Executes Share Buyback to Enhance Shareholder Value
Positive
Apr 1, 2025

Hiscox Ltd has executed a share buyback program, purchasing 50,000 ordinary shares on 31 March 2025, with prices ranging from 1,174.00p to 1,196.00p per share. This move is part of the company’s strategy to manage its capital structure and return value to shareholders, potentially enhancing shareholder value and indicating confidence in the company’s financial health.

Stock Buyback
Hiscox Ltd Executes Share Buyback to Enhance Shareholder Value
Positive
Mar 31, 2025

Hiscox Ltd has executed a share buyback program, purchasing 45,000 of its own ordinary shares at an average price of 1,194.18 GBp per share. This move, part of a previously announced buyback initiative, is aimed at optimizing the company’s capital structure and potentially enhancing shareholder value by reducing the number of shares outstanding.

Stock BuybackBusiness Operations and Strategy
Hiscox Executes Share Buyback to Optimize Capital Structure
Positive
Mar 28, 2025

Hiscox Ltd has executed a share buyback program, purchasing 45,000 of its own ordinary shares through Peel Hunt LLP. The shares were bought at prices ranging from 1,171.00 GBp to 1,188.00 GBp and will be cancelled, reflecting the company’s strategy to manage its capital structure and potentially enhance shareholder value.

Stock BuybackBusiness Operations and Strategy
Hiscox Ltd Executes Share Buyback to Optimize Capital Structure
Positive
Mar 27, 2025

Hiscox Ltd has executed a share buyback program, purchasing 45,000 ordinary shares at a volume-weighted average price of 1,187.53 GBp per share. This move is part of a strategic initiative to optimize the company’s capital structure and potentially enhance shareholder value by reducing the number of shares outstanding.

Stock BuybackBusiness Operations and Strategy
Hiscox Ltd Executes Share Buyback Program
Positive
Mar 26, 2025

Hiscox Ltd has executed a share buyback program, purchasing 45,000 ordinary shares at a volume-weighted average price of 1,167.79 GBp. This move is part of a strategic initiative to manage the company’s capital structure and potentially enhance shareholder value by reducing the number of shares in circulation.

Stock BuybackBusiness Operations and Strategy
Hiscox Ltd Executes Share Buyback Program
Positive
Mar 25, 2025

Hiscox Ltd has executed a share buyback program, purchasing 45,000 of its own ordinary shares at prices ranging from 1,157.00 GBp to 1,173.00 GBp, with a volume-weighted average price of 1,164.82 GBp. This move is part of a strategic initiative announced in February 2025, aimed at optimizing the company’s capital structure and potentially enhancing shareholder value by reducing the number of shares outstanding.

Stock BuybackBusiness Operations and Strategy
Hiscox Ltd Executes Strategic Share Buyback
Positive
Mar 24, 2025

Hiscox Ltd has executed a share buyback program, purchasing 45,000 of its own ordinary shares at prices ranging from 1,158 to 1,179 pence per share, with an average price of 1,172.18 pence. This move is part of the company’s strategic efforts to manage its capital structure and enhance shareholder value, potentially impacting its market positioning and signaling confidence in its financial health.

Stock BuybackBusiness Operations and Strategy
Hiscox Executes Share Buyback Program
Positive
Mar 21, 2025

Hiscox Ltd has executed a share buyback program, purchasing 45,000 ordinary shares at prices ranging from 1,156.00 to 1,169.00 pence per share. This move is part of a strategic initiative to enhance shareholder value, and the purchased shares will be cancelled, potentially impacting the company’s stock value and market perception.

Stock BuybackBusiness Operations and Strategy
Hiscox Executes Share Buyback to Enhance Shareholder Value
Positive
Mar 20, 2025

Hiscox Ltd has executed a share buyback program, purchasing 45,000 ordinary shares at prices ranging from 1,140.00 to 1,154.00 GBp. This move, part of an ongoing strategy announced in February 2025, aims to enhance shareholder value by reducing the number of shares in circulation, potentially impacting the company’s stock price and market perception positively.

Stock Buyback
Hiscox Ltd Executes Share Buyback Program
Neutral
Mar 18, 2025

Hiscox Ltd has executed a share buyback program, purchasing 40,511 ordinary shares at prices ranging from 1,120.00 to 1,133.00 pence per share, with an average price of 1,125.42 pence. The repurchased shares will be canceled, potentially impacting the company’s stock value and shareholder equity by reducing the number of shares outstanding, which may enhance earnings per share and return on equity.

Shareholder MeetingsFinancial Disclosures
Hiscox Ltd Releases 2025 AGM Notice and 2024 Annual Report
Neutral
Mar 17, 2025

Hiscox Ltd has announced the release of several key documents for its shareholders, including the Notice of the 2025 Annual General Meeting, the Form of Proxy for the meeting, the 2024 Annual Report and Accounts, and the 2025 Scrip Dividend Scheme Circular. These documents have been submitted to the National Storage Mechanism and are available on the company’s website. The Annual General Meeting is scheduled to take place in Bermuda on May 15, 2025. This announcement ensures transparency and provides shareholders with essential information to engage in the company’s governance and financial planning.

Stock BuybackBusiness Operations and Strategy
Hiscox Ltd Executes Share Buyback Program
Positive
Mar 17, 2025

Hiscox Ltd has executed a share buyback program, purchasing 45,000 ordinary shares at an average price of 1,114.89 GBp per share. This move is part of a previously announced buyback initiative and reflects the company’s strategy to manage its capital structure, potentially enhancing shareholder value.

Stock BuybackBusiness Operations and Strategy
Hiscox Ltd Executes Share Buyback to Enhance Shareholder Value
Positive
Mar 14, 2025

Hiscox Ltd has executed a share buyback program, purchasing 65,000 ordinary shares at prices ranging from 1,116.00 to 1,149.00 GBp, with a volume-weighted average price of 1,130.85 GBp. This move, conducted through Peel Hunt LLP, is part of the company’s strategy to enhance shareholder value by reducing the number of outstanding shares, potentially increasing earnings per share and signaling confidence in the company’s financial health.

Stock BuybackBusiness Operations and Strategy
Hiscox Executes Share Buyback Program
Positive
Mar 13, 2025

Hiscox Ltd has executed a share buyback program, purchasing 50,000 ordinary shares at prices ranging from 1,132.00 GBp to 1,146.00 GBp, with a volume-weighted average price of 1,140.25 GBp. The purchased shares will be canceled, which is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value.

Stock BuybackBusiness Operations and Strategy
Hiscox Ltd Executes Share Buyback Program
Positive
Mar 12, 2025

Hiscox Ltd has executed a share buyback program, purchasing 45,000 ordinary shares at prices ranging from 1,128.00 to 1,148.00 GBp, with a volume-weighted average price of 1,136.42 GBp. The repurchased shares will be cancelled, which is part of the company’s strategy to optimize its capital structure and potentially enhance shareholder value.

Stock BuybackBusiness Operations and Strategy
Hiscox Ltd Executes Share Buyback to Enhance Shareholder Value
Positive
Mar 11, 2025

Hiscox Ltd has executed a share buyback program, purchasing 45,000 ordinary shares at a volume-weighted average price of 1,152.38 pence per share. This move is part of its strategic financial management to enhance shareholder value by reducing the number of outstanding shares, potentially increasing earnings per share and supporting the company’s stock price.

Stock Buyback
Hiscox Executes Share Buyback to Enhance Shareholder Value
Positive
Mar 11, 2025

Hiscox Ltd has executed a share buyback program, purchasing 45,000 of its ordinary shares through Peel Hunt LLP. The buyback, part of a previously announced program, aims to enhance shareholder value by reducing the number of shares in circulation, potentially increasing earnings per share and demonstrating confidence in the company’s financial health.

Stock BuybackBusiness Operations and Strategy
Hiscox Ltd Executes Share Buyback to Enhance Shareholder Value
Positive
Mar 11, 2025

Hiscox Ltd has executed a share buyback program, purchasing 45,000 ordinary shares at a volume-weighted average price of 1,155.12 GBp per share. This strategic move is part of the company’s ongoing efforts to manage its capital structure and enhance shareholder value, potentially impacting its market positioning and investor relations.

Stock BuybackBusiness Operations and Strategy
Hiscox Executes Share Buyback to Enhance Shareholder Value
Positive
Mar 6, 2025

Hiscox Ltd has announced the purchase of 45,000 ordinary shares as part of its share buyback programme, with the shares being acquired at prices ranging from 1,180.00 GBp to 1,196.00 GBp. This move is part of Hiscox’s strategy to manage its capital structure and enhance shareholder value, potentially impacting its market positioning and investor relations.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.